Aktien Sensor

Syngene International has made a significant move in the biotech industry by acquiring a state-of-the-art biologics manufacturing facility in Baltimore, positioning the company for success in the lucrative biologics market.

Zoetis A has delivered a remarkable 280% return on investment over the past decade, cementing its position as a market leader with a market value of nearly $78 billion.